[PDF] Top 20 Narrativas de experiencia en educación y pedagogía de la memoria
Has 10000 "Narrativas de experiencia en educación y pedagogía de la memoria" found on our website. Below are the top 20 most common "Narrativas de experiencia en educación y pedagogía de la memoria".
Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
... of lenalidomide involved a heavily pretreated popula- tion with relapsed or refractory disease, with a consequent impact on duration of therapy and adverse ...drugs, lenalidomide and thalidomide in ... See full document
6
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
... of therapy, including bortezomib, carfilzomib, thali- domide, lenalidomide, and corticosteroids, were enrolled in the dose-escalation phase, in which oral MLN9708 was administered on days 1, 8, and 15 of a ... See full document
11
An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation
... Abstract: Atrial fibrillation is the most common arrhythmia in the elderly. It is responsible for significant morbidity and mortality from cardioembolic complications like stroke. As a result, atrial fibrillation ... See full document
5
Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review
... Abstract: Multiple myeloma (MM) is a clonal malignancy characterized by the proliferation of malignant plasma cells in the bone marrow and the production of monoclonal ...(thalidomide, lenalidomide, ... See full document
7
Multiple myeloma presenting with high output heart failure and improving with anti angiogenesis therapy: two case reports and a review of the literature
... and evidence of pulmonary ...diuretic therapy, the patient's volume status ...1). Based on the high output values obtained at catheterization, a thyroid panel was obtained which was ...aforementioned ... See full document
13
Lenalidomide for the treatment of relapsed and refractory multiple myeloma
... Abstract: Lenalidomide is an amino-substituted derivative of thalidomide with direct antipro- liferative and cytotoxic effects on the myeloma tumor cell, as well as antiangiogenic activity and ... See full document
75
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
... renal impairment, nausea, and headache was observed in the daptomycin therapy group. Elevated creatine phosphokinase (CPK) levels were reported, but these resolved rapidly after the discontinuation of daptomycin ... See full document
12
Therapy for multiple myeloma historical perspective: review of literature
... the role of high—dose chemotherapy (HDCT) with stem cell support in improving the outcome of patients with multiple myeloma has been evaluated in several clinical ...Council Myeloma VII Trial ... See full document
9
Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes
... In early studies with pramipexole there was a reduction of the mean ILRS score from 17 (SD 4.3) to 7.8 (SD 4.9) (P<0.0001) in a two-centre, open-label, questionnaire-based study on 23 patients with RLS (Becker ... See full document
14
Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
... 1 evidence showing that donepezil has an effect in improving or limiting deterioration in behavior or mood in the short to medium term (Birks & Harvey 2003; NICE 2005; Table ...2 evidence of significant ... See full document
17
Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes
... Notes: This figure depicts the hormonal interactions that are key in normal glucose homeostasis. Normal fasting glucose homeostasis involves the regulation of glucose utilization and production, as well as the filtration ... See full document
26
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
... to its many drug interactions and association with nephrotoxicity, hypertension, and pos- sibly ...however its teratogenic potential considerably limits the use in female of childbearing ... See full document
20
Lixivaptan – an evidence-based review of its clinical potential in the treatment of hyponatremia
... and the V2 form predominates in the kidney, notably in the collecting duct. There, binding of vasopressin on the basolateral side of the principal cell activates a G s -coupled protein which, in turn, activates adenylyl ... See full document
13
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
... during therapy with mavrilimumab. In addition, its efficacy should also be monitored using imaging techniques to evaluate effects on structural progression and head-to-head studies with other biologic ... See full document
9
An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
... for acute attacks of HAE was generally well tolerated. The results demonstrated that patients were able to decide when the initiation of treatment was appropriate, and they were able to safely self-administer icatibant ... See full document
12
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
... increased incidence of injection site reactions (19% weekly and 15% biweekly vs 8% placebo) and conjunctivitis (19% weekly and 14% biweekly vs 8% placebo) were the most commonly reported adverse events in the dupilumab ... See full document
5
Download Download PDF
... of myeloma cells to bone marrow stromal cells, and thereby inhibit the enhanced secre- tion of migratory factors, such as interleukin (IL)-, TNF-α, and vascular endothelial growth factor (VEGF) ...(-). ... See full document
10
Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma
... MM based on its antiangiogenic activity and clinical activity in refractory or relapsed myeloma ...[7]. Lenalidomide (LND) is a potent novel thalidomide analog which demonstrated remarkable ... See full document
126
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
... a role for enzalutamide in all patients with metastatic CRPC is hinted at by the data from the Phase I/II studies, where enzalutamide appeared efficacious (and potentially even more efficacious) in ... See full document
22
Regorafenib: an evidence-based review of its potential in patients with advanced liver cancer
... After its safety and pharmacological properties was studied in Phase I trials, a Phase II study evaluating the role of Regorafenib in patients with advanced HCC who progressed on sorafenib therapy ... See full document
6
Related subjects